Evidence map›Paper›PMID 23064229›Full record

ArticleNature2012

Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat.

Claudia Carrieri, Laura Cimatti, Marta Biagioli, Anne Beugnet, Silvia Zucchelli, Stefania Fedele, Elisa Pesce, Isidre Ferrer, Licio Collavin, Claudio Santoro and 5 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Nature, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 570 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
570citing papers in PubMed, 1 pooled it
22.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

570 citing papers in PubMed, 1 synthesis or guideline pooled it, 1,022 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Mechanistic study of antisense long non-coding RNAExploration of targeted anti-tumor therapy · 2026
    Article
  15. Article
  16. Theranostics · 2026
    Article
  17. Article
  18. Review
  19. Article
  20. Review

510 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Claudia CarrieriArea of Neuroscience, International School for Advanced Studies (SISSA), via Bonomea 265, 34136 Trieste, Italy.
Laura Cimatti
Marta Biagioli
Anne Beugnet
Silvia Zucchelli
Stefania Fedele
Elisa Pesce
Isidre Ferrer
Licio Collavin
Claudio Santoro
Alistair R R Forrest
Piero Carninci
Stefano Biffo
Elia Stupka
Stefano Gustincich
Scuola Internazionale Superiore di Studi Avanzati · ITRIKEN Center for Integrative Medical Sciences · JPUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITBellvitge University Hospital · ESConsorzio Interuniversitario per le Biotecnologie · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most of the mammalian genome is transcribed. This generates a vast repertoire of transcripts that includes protein-coding messenger RNAs, long non-coding RNAs (lncRNAs) and repetitive sequences, such as SINEs (short interspersed nuclear elements). A large percentage of ncRNAs are nuclear-enriched with unknown function. Antisense lncRNAs may form sense-antisense pairs by pairing with a protein-coding gene on the opposite strand to regulate epigenetic silencing, transcription and mRNA stability. Here we identify a nuclear-enriched lncRNA antisense to mouse ubiquitin carboxy-terminal hydrolase L1 (Uchl1), a gene involved in brain function and neurodegenerative diseases. Antisense Uchl1 increases UCHL1 protein synthesis at a post-transcriptional level, hereby identifying a new functional class of lncRNAs. Antisense Uchl1 activity depends on the presence of a 5' overlapping sequence and an embedded inverted SINEB2 element. These features are shared by other natural antisense transcripts and can confer regulatory activity to an artificial antisense to green fluorescent protein. Antisense Uchl1 function is under the control of stress signalling pathways, as mTORC1 inhibition by rapamycin causes an increase in UCHL1 protein that is associated to the shuttling of antisense Uchl1 RNA from the nucleus to the cytoplasm. Antisense Uchl1 RNA is then required for the association of the overlapping sense protein-coding mRNA to active polysomes for translation. These data reveal another layer of gene expression control at the post-transcriptional level.

Indexed as

AnimalsAnti-Bacterial AgentsCell LineHumansMaleMiceProtein BiosynthesisRNA, AntisenseSequence InversionShort Interspersed Nucleotide ElementsSirolimusUbiquitin ThiolesteraseAnti-Bacterial AgentsRNA, AntisenseSirolimusUbiquitin ThiolesteraseUchl1 protein, mouse

Identifiers

PMID23064229
OpenAlexW2050982262

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.